Ledger.Open graph →
SEC Form D · filed February 1, 2018

NexImmune, Inc

Offering
$25.0M
Sold
$21.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Tony Yao · Gaithersburg, MDDirectorScott Carmer · Gaithersburg, MDExec · DirectorTimothy Bertram · Gaithersburg, MDDirectorAlan Roemer · Gaithersburg, MDDirectorPaul D'Angio · Gaithersburg, MDDirectorRobert Spiegel · Gaithersburg, MDDirectorAlain Cappeluti · Gaithersburg, MDExecBing Yao · Gaithersburg, MDDirectorKipp J. Deveer · Los Angeles, CAExecCharles N. Arduini · Los Angeles, CADirectorDeborah R. Dang · Portland, ORDirectorChristopher H. Winship · Portland, ORDirectorHodong R. Nam · Portland, ORDirectorNicolas R. El Baze · Portland, ORDirectorOleg Nodelman · Napa, CAExec · DirectorSarah Marriott · Napa, CADirectorJonathan W. Sarver · Asheville, NCExec · DirectorMoises Eilemberg · San Diego, CADirectorErik Van Stek · San Diego, CADirectorHendrik Hanselaar · San Diego, CAExecGregory Aretakis · Milwaukee, WIDirectorJamie L. Greene · Asheville, NCDirectorJared Marcus · New York, NYDirectorBrad A. Cowdroy · GRAND CAYMAN, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗